China is strengthening antimonopoly measures in the pharmaceutical market

China is strengthening antimonopoly measures in the pharmaceutical market
Photo: https://globalcompetitionreview.com/pharmaceuticals/china-reiterates-commitment-tackle-antitrust-issues-in-pharma-sector 03.02.2022 650

The Chinese authorities have announced tougher law enforcement measures to curb the monopolization of the drug market in the country. According to the Ministry of Industry, the government is committed to creating a favourable business environment in the Chinese market, informs Reuters.

This measure follows the November government's recommendations to eliminate the active pharmaceutical ingredients market monopoly. China's Ministry of Industry has stepped up measures against unfair competition in a new statement. Antimonopoly legislation will also be strengthened to reduce the shortage of medicines and APIs, and in addition, new rules for the circulation of APIs will be prepared and adopted.

Source: Reuters

pharmaceutical markets  China 

Share with friends

Related content